UDI: Value Beyond Compliance
In this AHRMM webcast, Karen Conway, executive director of industry relations and value at GHX discusses her research with the FDA on the value of UDI adoption in health care organizations.
AHRMM’s Mike Schiller, senior director of supply chain, joins the conversation by describing the actions AHRMM is taking with the Learning UDI Community (LUC) to identify adoption practices and move beyond compliance.
Related Resources
Toolkits/Methodology
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision…
Magazine & Journal Articles
Managing contract pricing more effectively—from creation to renewal or expiration—can deliver real operational and financial benefits for hea
Advisory
The FDA UDI ruling has finally arrived - the proposed rule has published.
Advisory
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<
Advisory
The final regulations that provide guidance on the excise tax imposed on the sale of certain medical devices, enacted by the Health Care and Educ
White Papers
This white paper explores the realities facing healthcare delivery, some of the new models being developed and what they could mean for the s